Skip to main content

Share story

Security

Operation Endgame Takedown dismantles Amadey and StealC malware infrastructure

Law enforcement action has resulted in the disruption of infrastructure supporting the Amadey and StealC malware programs. The Hackers News reported on X on June 24, 2026, that Operation Endgame dismantled key components of this malware infrastructure. The malware in question is used to steal data and deliver additional payloads, the post explained. The operation led to significant seizures and takedowns according to authorities. Specifically, 326 servers were dismantled. A total of 142 domains were taken down. Recovery efforts yielded 27 million stolen credentials. Additionally, authorities restricted over 47 million dollars worth of criminal cryptocurrency assets. The post described the development as cybercrime crews losing part of their malware supply chain. It presented the figures as outcomes of the operation against the infrastructure behind Amadey and StealC. No other details, such as the identities of the authorities involved or the locations of the affected servers and domains, were included in the X post. The report remained focused on these quantitative results from the takedown. This single event centers on the reported dismantling of the specified malware infrastructure through Operation Endgame.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Hacker News (X) and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.